A, Disease-free survival (DFS) among patients with R0 stage I to III disease, according to molecular group, using pan-genomic classifier (training cohort). B, Overall survival (OS) among patients with stage I to IV disease, according to molecular group, using pan-genomic classifier (training cohort). C, DFS among patients with R0 stage I to III disease, according to molecular group, using the 3-dimensional (3-D) targeted classifier (validation cohort). D, DFS among patients with R0 stage I to III disease, according to molecular group, using the DNA-based targeted classifier (validation cohort). Survival curves were obtained with Kaplan-Meier estimates.